Residential College | false |
Status | 已發表Published |
Editorial: Immunity in the development of anti-cancer drug resistance | |
Meng, Ya1; Wang, Haitao2; Li, Xuebing3; Wu, Xinwei2; Sun, Heng4,5,6 | |
2022-12-16 | |
Media | Frontiers Media S.A. |
DOI | 10.3389/fphar.2022.1120037 |
Keyword | Cancer Therapy Drug Resistance Immunity Precision Oncology Tumor Microenvironment |
Language | 英語English |
URL | View the original |
Scopus ID | 2-s2.0-85145392183 |
Fulltext Access | |
Citation statistics | |
Document Type | Other |
Collection | Faculty of Health Sciences Cancer Centre Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau |
Corresponding Author | Meng, Ya; Wang, Haitao; Li, Xuebing; Wu, Xinwei; Sun, Heng |
Affiliation | 1.Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital, Zhuhai Hospital Affiliated With Jinan University, Zhuhai, China 2.Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, United States 3.Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China 4.Cancer Center, Faculty of Health Sciences, University of Macau, Macau, Macau SAR, China 5.MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau, Macau SAR, China 6.Zhuhai Research Institute, University of Macau, Zhuhai, Macau SAR, China |
Recommended Citation GB/T 7714 | Meng, Ya,Wang, Haitao,Li, Xuebing,et al. Editorial: Immunity in the development of anti-cancer drug resistance. 2022-12-16. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment